Navigation Links
Lesser Know Facts about Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic pulmonary fibrosis (IPF) is a disease whose cause and cure are not studied and there is also no known treatment for it till date//. It is a lung disease characterized by scarring in the lungs causing fibrosis and slow deterioration of the entire organ (lung).

Statistics show that approximately 83,000 Americans suffer from the disease and 31000 new cases are diagnosed every year. Ten years ago Jean Thompson became a prey to the disease and now her twin sister joy Thompson is suffering from this incurable lung disease. It is a very sad situation that till date there is no accepted treatment. New research is done by patient-centered non-profit organization called the Coalition for Pulmonary Fibrosis (CPF). This has done a lot to help patients suffering from IPF. Mark Shreve, CEO of the CPF said that when it affected the twin sisters they have not heard of the disease. This is because there were no resources available to conduct clinical trials for disease.

When Jean was suffering from the disease there was no correct diagnosis which brought her to the last stage of the disease. Hence CPF helped patients educate themselves about the disease. CPF was formed by a group of physicians, patients, family members and non-profit organizations who saw a huge unmet need. It has set various options of treatment for those suffering from IPF such as lung transplantation and pulmonary rehabilitation. CPF has added a network of 35 support groups and important patient access to physician referrals.

In 1999 the American Thoracic Society released a consensus statement regarding the diagnosis and treatment of the disease. It is thought that genetics may play a role in the causes of IPF for some patients. But the genetic link has not been pinpointed. several investigational therapies are in the pipeline such as interferon gamma 1-b, pirfenidone, imatinib mesylate, etanerrcept, and iloprost-listed alpha that may hold the key to life-saving treatments for the disease.

Related medicine news :

1. UK Witnesses Lesser Number Of Flu Cases
2. Botox Treatment Now With A Lesser Dose And Increased Safety
3. Differently Wired and Gay – Are They Children of a Lesser God
4. Research Finds Lesser Rectal Cancer Risks Associated with Prostatic Irradiation
5. Lesser Health care associated infections in Irish Hospitals.
6. Lesser Calories for Longer Life
7. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
8. Lesser the Better- Minimally Invasive Surgery Breakthrough
9. Facts about Common Cold and Flu
10. Plane Facts: Beneficial To Have Medics Full-Time In Super Jets
11. The Little Known Facts of Junk DNA
Post Your Comments:

(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... (AIS) is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: Three ... learned from three innovative value-based care arrangements: Essentia Health and UCare, MissionPoint ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... DataTrade Solutions Inc., a Healthcare IT consulting, development and support company. The purchase ... technical experience available within DataTrade to extend the services currently provided by Healthjump. ...
(Date:11/30/2015)... (PRWEB) , ... November 30, ... ... ), a leading provider of enterprise Time and Attendance/Workforce Management cloud-based ... in the Microsoft Partner Program with competencies in the Application Development, demonstrating ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... 2016. In 2016, expected coding changes are likely to include new codes for ... It’s not easy to understand the effects of code changes in musculoskeletal, radiology ...
(Date:11/29/2015)... Birmingham, Lake Orion, Clarkston, Metamora, Michigan (PRWEB) , ... ... ... Women's Excellence is once again accredited by the American Institute ... peer review process that allows practices to demonstrate that they meet or ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015  Novartis will demonstrate the strength ... th American Society of Hematology (ASH) Annual Meeting. ... as well as supportive care, including key findings in ... cell therapies. The ASH Annual Meeting will be held ... Novartis Oncology . "We will be presenting ...
(Date:11/30/2015)... BOSTON , November 30, 2015 ... new medicines directed at up to 10 G protein-coupled ... PFE ) to research and develop potential new ... (GPCR) targets across multiple therapeutic areas. --> ... and development company and wholly-owned subsidiary of Sosei Group ...
(Date:11/30/2015)... , November 30, 2015 ... or the "Company") announced today that it was informed by ... and Drug Safety (MFDS) has approved its Exablate Neuro ... --> --> Insightec,s Exablate ... treatment alternative that combines two technologies: Focused Ultrasound, which ...
Breaking Medicine Technology: